Procognia (Israel) signed a binding three-year letter of intent with Cytech – a Hong-Kong based distributor of life sciences products – for the exclusive distribution of Procognia’s blood sugar analysis kits in China and Taiwan. According to the deal, Procognia will receive a percentage of sales and revenue from the analysis services. The Glycoscope kit is designed for pharmaceutical companies and research laboratories to identify and monitor the structure of sugars in proteins during the development and production of biological drugs and vaccines, as well as stem cell research. View and share
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments